Paula Soteropoulos Uni Qure N.V. (QURE) insider trading activity

Paula Soteropoulos is Director of uniQure N.V.. Currently has a direct ownership of 20,203 shares of QURE, which is worth approximately $115,157. The most recent transaction as insider was on Jun 13, 2024, when has been sold 2,220 shares (Ordinary Shares) at a price of $5.14 per share, resulting in proceeds of $11,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K

0% 3M change

9.9% 12M change

Total Value Held $115,157

Paula Soteropoulos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2024	SELL Open market or private sale	$11,410 $5.14 p/Share	2,220 Reduced 9.9%	20,203 Ordinary Shares
Jun 16 2023	SELL Open market or private sale	$43,202 $18.99 p/Share	2,275 Reduced 9.21%	22,423 Ordinary Shares
Jun 13 2023	BUY Grant, award, or other acquisition	-	8,700 Added 26.05%	24,698 Ordinary Shares
Feb 27 2023	SELL Open market or private sale	$7,668 $19.97 p/Share	384 Reduced 2.34%	15,998 Ordinary Shares
Jan 18 2023	SELL Open market or private sale	$135,540 $22.59 p/Share	6,000 Reduced 26.81%	16,382 Ordinary Shares
Jan 18 2023	BUY Exercise of conversion of derivative security	$32,220 $5.37 p/Share	6,000 Added 21.14%	22,382 Ordinary Shares
Dec 14 2022	SELL Open market or private sale	$89,034 $23.43 p/Share	3,800 Reduced 18.83%	16,382 Ordinary Shares
Dec 14 2022	BUY Exercise of conversion of derivative security	-	3,800 Added 15.85%	20,182 Ordinary Shares
Dec 13 2022	SELL Open market or private sale	$70,350 $23.45 p/Share	3,000 Reduced 15.48%	16,382 Ordinary Shares
Dec 13 2022	BUY Exercise of conversion of derivative security	$16,110 $5.37 p/Share	3,000 Added 13.4%	19,382 Ordinary Shares
Nov 29 2022	SELL Open market or private sale	$157,356 $25.38 p/Share	6,200 Reduced 27.46%	16,382 Ordinary Shares
Nov 29 2022	BUY Exercise of conversion of derivative security	-	6,200 Added 21.54%	22,582 Ordinary Shares
Jun 15 2022	BUY Grant, award, or other acquisition	-	9,080 Added 35.66%	16,382 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$10,055 $16.87 p/Share	596 Reduced 7.55%	7,302 Ordinary Shares
Feb 24 2022	BUY Grant, award, or other acquisition	-	1,534 Added 16.26%	7,898 Ordinary Shares
Mar 02 2021	SELL Open market or private sale	$18,950 $37.6 p/Share	504 Reduced 7.34%	6,364 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	2,382 Added 25.75%	6,868 Ordinary Shares

Also insider at

RLYB

Rallybio Corp Healthcare

Director

MGTA

Magenta Therapeutics, Inc. Healthcare